Selective estrogen receptor alpha modulation during body weight cycling
体重循环期间选择性雌激素受体α调节
基本信息
- 批准号:225908252
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Clinical Research Units
- 财政年份:2012
- 资助国家:德国
- 起止时间:2011-12-31 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Body weight (BW) cycling including BW -regain after weight loss is associated with marked changes in energy expenditure (EE) and adipose tissue (AT) metabolism. Since these processes are sex-specifically controlled, we focus on sexual dimorphisms in metabolic processes during BW-cycling and aimed to elucidate the role of ER! in lipogenesis and lipolysis in the AT. We established a diet-induced (DIO) mouse model with a subsequent reduction of BW by caloric restriction (CR) followed by adaptive feeding, and a regain-period. We observed that female mice responded to CR with an increase in lipolytic activity, and augmented lipid-oxidation leading to more efficient weight loss compared to male animals. These processes likely involve sexual dimorphic regulation of ATGL and estrogen receptor alpha (ERα)-dependent signaling in AT. In addition, female mice showed higher levels of EE during BW-cycling. This is in accordance with a recently published report demonstrating that ERα-deletion in neurons of the ventromedial hypothalamic nucleus (VMH) results in reduced EE. Based on these data we hypothesize that ERα mediates its metabolic action during BW-cycling in a bimodal manner in the VMH and AT. Thus, the aim of the present project for a second funding period is the detailed analysis of ERα in the VMH and AT as a pharmacological target for the support of BW-reduction and prevention of BW-regain after initial weight loss. Our studies will focus on the characterization of subtype- and tissue/ cellselective activation of ERα following the concept of selective estrogen receptor modulation (SERM). After phenotyping of AT-specific ERα-deficient mice during the first funding phase, we will start with the metabolic analysis of VMH-specific ERα-deficient (ERαlox/lox/ SF-1 Cre) mice during BW-cycling. In parallel we will study molecular SERM-components (ERα, nuclear cofactors, target genes) in the VMH and AT during BW-cycling and in-vitro. Finally, newly synthesized SERM-compounds specific for ER! will be tested in-vitro and in-vivo. This projects aims for an improved understanding of SERM compounds as a pharmacological intervention in obesity.
体重(BW)骑自行车在体重减轻后包括BW-Regain与能量消耗(EE)和脂肪组织(AT)代谢的明显变化有关。由于这些过程是对性别特定控制的,因此我们专注于BW-Cycling期间代谢过程中的性二态性,并旨在阐明ER的作用!在AT中的脂肪生成和脂解中。我们建立了饮食诱导的(DIO)小鼠模型,随后通过热量限制(CR)降低了BW,然后进行自适应喂养和重新恢复。我们观察到,雌性小鼠对CR的反应随脂溶作用的增加而反应,并且与雄性动物相比,脂质氧化增加导致体重增加更有效。这些过程可能涉及AT中ATGL和雌激素受体α(ERα)依赖性信号的性二态调节。此外,雌性小鼠在BW周期期间显示出较高的EE水平。这与最近发表的一份报告相符,该报告表明,腹膜下丘脑核us(VMH)的神经元中的ERα脱落导致EE减少。基于这些数据,我们假设ERα在BW-Cycling期间以双峰方式在VMH和AT中介导其代谢作用。这是第二个资金期间本项目的目的是对VMH中的ERα进行详细分析,并作为支持BW还原和预防BW-Regain后重量减肥后的药物目标。我们的研究将集中于选择性雌激素受体调制(SERM)概念的ERα亚型和组织/细胞选择性激活的表征。在第一个融资阶段对AT特异性ERα缺陷小鼠进行表型后,我们将从对BW-Cycling期间VMH特异性ERα缺陷型(ERαLox/ Lox/ SF-1 Cre)小鼠的代谢分析开始。同时,我们将研究VMH和BW-Cycling和Vitro期间的分子Serm component(ERα,核辅助因子,靶基因)。最后,新合成的Serm-Compounds特定于ER!将在体外和体内进行测试。该项目的目的是提高对Serm化合物的理解,作为肥胖症的药物干预。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professor Dr. Ulrich Kintscher其他文献
Professor Dr. Ulrich Kintscher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professor Dr. Ulrich Kintscher', 18)}}的其他基金
Adipose tissue ATGL regulates cardiac energy metabolism in heart failure
脂肪组织 ATGL 调节心力衰竭中的心脏能量代谢
- 批准号:
431080330 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Research Grants
The role of adipose tissue estrogen receptors during body weight loss and the maintenance of reduced weight
脂肪组织雌激素受体在体重减轻和维持体重减轻过程中的作用
- 批准号:
139879850 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Clinical Research Units
Sex differences in adipose tissue lipolysis and pathological cardiac hypertrophy
脂肪组织脂肪分解和病理性心脏肥大的性别差异
- 批准号:
79541510 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Research Units
相似国自然基金
新型选择性雌激素相关受体α(ERRα)激动剂的发现及其抗2型糖尿病的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
新型选择性雌激素相关受体α(ERRα)激动剂的发现及其抗2型糖尿病的作用机制研究
- 批准号:82273858
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
新型骨架选择性雌激素受体降解剂的发现及抗肿瘤活性研究
- 批准号:81973165
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
新型选择性ERRα小分子反向激动剂的设计、合成及其在乳腺癌治疗中的研究
- 批准号:21807045
- 批准年份:2018
- 资助金额:23.5 万元
- 项目类别:青年科学基金项目
靶向雌激素受体非核效应信号通路特异性小分子化合物的设计、合成及其对心血管的选择性保护作用研究
- 批准号:81773557
- 批准年份:2017
- 资助金额:63.0 万元
- 项目类别:面上项目
相似海外基金
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures
双磷酸盐如何影响骨基质和重塑:对非典型股骨骨折的影响
- 批准号:
10586949 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of P4HA1 in Endocrine Resistance of Breast Cancer
P4HA1在乳腺癌内分泌抵抗中的作用
- 批准号:
10571404 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation
神经纤维蛋白对 ER-α 和核斑点转录后基因调控的影响
- 批准号:
10744501 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
-- - 项目类别: